Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-08-31Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventionsJournal of Psychedelic Studies · 2026-07-02Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health SymptomsJournal of Drug Issues · 2026-06-30Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic reviewJournal of Affective Disorders Reports · 2026-06-30Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-14Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-04Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-04Corrigendum to: “Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape”Australian & New Zealand Journal of Psychiatry · 2026-05-17Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-13Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilizationFrontiers in Psychiatry · 2026-05-12Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium DynamicsBiological Psychiatry · 2026-04-24Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-04-24Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-04-24356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-AnalysisBiological Psychiatry · 2026-04-246. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-EfficacyBiological Psychiatry · 2026-04-24Prevalence and Correlates of Past-Year Psilocybin Use in the United StatesAmerican Journal of Psychiatry · 2026-04-21Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-04-18CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical TrialClinicalTrials.gov · 2026-04-12Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFOCUS The Journal of Lifelong Learning in Psychiatry · 2026-03-31The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-03-31Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17Enlightenment in a Pill-Testing the Efficacy of PsilocybinJAMA Psychiatry · 2026-03-17Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-02-24Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effectsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-02-11Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybinMolecular Psychiatry · 2026-02-02MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of FearBiological Psychiatry · 2026-01-31Regarding “The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses”Translational Psychiatry · 2026-01-30Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-01-26Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscapeAustralian & New Zealand Journal of Psychiatry · 2025-12-16Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Sudden Loss of Consciousness Following Psilocybin IngestionAmerican Journal of Psychiatry · 2025-11-30Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trialTranslational Psychiatry · 2025-11-12Psilocybin Outside the ClinicJAMA Psychiatry · 2025-11-04Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injuryMolecular Psychiatry · 2025-11-0492. Mushrooms and Mania: Differentiating Psilocybin-Induced Mania From First-Break Bipolar ManiaJournal of the Academy of Consultation-Liaison Psychiatry · 2025-10-31Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30Compassionate use of psilocybin for treatment-resistant depression in GermanyThe Lancet Psychiatry · 2025-09-22Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysisTranslational Psychiatry · 2025-08-28Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trialGeneral Hospital Psychiatry · 2025-08-11Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05Therapeutic and legal aspects of psilocybin in cancer-related depressionFrontiers in Psychiatry · 2025-08-03Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 casesNordic Journal of Psychiatry · 2025-07-09Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyComprehensive Psychiatry · 2025-07-01Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-06-30The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analysesTranslational Psychiatry · 2025-06-15Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stressTranslational Psychiatry · 2025-06-13Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesMolecular Psychiatry · 2025-04-25Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisThe International Journal of Psychiatry in Medicine · 2025-04-24Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional AnalysisPharmacopsychiatry · 2025-04-16458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene ExpressionBiological Psychiatry · 2025-04-08630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-08194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-0858. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-0813. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-08Psilocybin has a narrow therapeutic window as an antidepressant treatmentProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-03-31The effect of low-dose psilocybin on brain neurotransmission and rat behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-03-28Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortexTranslational Psychiatry · 2025-03-24Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin TreatmentAmerican Journal of Psychiatry · 2025-02-28Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case reportBMC Psychiatry · 2025-02-27Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case reportPsychiatry Research · 2025-01-28Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label TrialAmerican Journal of Psychiatry · 2024-12-31Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialAmerican Journal of Psychiatry · 2024-12-31Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2024-12-31Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in Psychiatry and Psychotherapy · 2024-12-31Psilocybin increases emotional empathy in patients with major depressionMolecular Psychiatry · 2024-12-17Treatment Expectancies and Psilocybin vs Escitalopram for DepressionJAMA Psychiatry · 2024-12-09The many faces of psilocybin-related psychosis: A case seriesPsychiatry Research Case Reports · 2024-12-06Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine useFrontiers in Psychiatry · 2024-12-05Psilocybin increases optimistic engagement over time: computational modelling of behaviour in ratsTranslational Psychiatry · 2024-09-29Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction RelapseThe Journal of Clinical Psychiatry · 2024-08-24Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case reportFrontiers in Psychiatry · 2024-07-15Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility StudyFOCUS The Journal of Lifelong Learning in Psychiatry · 2024-06-30Bridging Psilocybin-Induced Changes in the Brain’s Dynamic Functional Connectome With an Individual’s Subjective ExperienceBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2024-06-30Psilocybin and 2C-B at Encoding Distort Episodic FamiliarityBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2024-06-25Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertensionFrontiers in Psychiatry · 2024-06-23Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorderFrontiers in Psychiatry · 2024-06-10Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”Frontiers in Psychiatry · 2024-06-031. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional MetamemoryBiological Psychiatry · 2024-04-28Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanismsMolecular Psychiatry · 2024-04-26The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybinBMC Psychiatry · 2024-04-24The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography StudyClinicalTrials.gov · 2024-04-18Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distressFrontiers in Psychiatry · 2024-04-17Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and SafetyJAMA Psychiatry · 2024-04-09Current situation regarding psychedelics and magic mushroom in KoreaEuropean Psychiatry · 2024-03-31Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainMolecular Psychiatry · 2024-02-19Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybinFrontiers in Psychiatry · 2024-01-07Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of PsilocybinBiological Psychiatry · 2024-01-04Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent ratsTranslational Psychiatry · 2023-12-13Psilocybin in Bipolar II Study Provides Preliminary Data on SafetyJAMA Psychiatry · 2023-12-05Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesionsEuropean Archives of Psychiatry and Clinical Neuroscience · 2023-11-06Peak Experiences: Lessons Learned from a Feasibility Study of Psilocybin-assisted Therapy for Demoralization in Patients Receiving Hospice CareJournal of the Academy of Consultation-Liaison Psychiatry · 2023-10-316.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the ResearchJournal of the American Academy of Child & Adolescent Psychiatry · 2023-09-30Manic episode following psilocybin use in a man with bipolar II disorder: a case reportFrontiers in Psychiatry · 2023-09-21Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorderFrontiers in Psychiatry · 2023-09-17Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrestsFrontiers in Psychiatry · 2023-08-23Must Psilocybin Always “Assist Psychotherapy”?American Journal of Psychiatry · 2023-07-11A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric historyPsychiatry Research Case Reports · 2023-04-25Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-09347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-0996. An Open Label Study of Synthetic Psilocybin in Bipolar Type II DepressionBiological Psychiatry · 2023-04-09More on psilocybinCurrent Psychiatry · 2023-01-31A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug AvailabilityAmerican Journal of Psychiatry · 2022-11-3019.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical ConsiderationsJournal of the American Academy of Child & Adolescent Psychiatry · 2022-09-30The use of classic psychedelics among adults: a Danish online survey study.Nordic Journal of Psychiatry · 2022-09-28From neuroplasticity to psychoplasticity: Psilocybin may reverse personality disorders and political fanaticismCurrent Psychiatry · 2022-08-31Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational Psychiatry · 2022-08-10Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational Psychiatry · 2022-08-01Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.Psychiatry Research · 2022-07-15Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.Frontiers in Psychiatry · 2022-07-06Association of Psilocybin Use in Adolescents with Major Depressive EpisodeEuropean Psychiatry · 2022-05-31Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.Frontiers in Psychiatry · 2022-05-17The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-AnalysisCurrent Psychiatry Research and Reviews · 2022-05-15P388. Open Label Psilocybin Administration in Severely Treatment Resistant DepressionBiological Psychiatry · 2022-04-27P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary EfficacyBiological Psychiatry · 2022-04-27Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.Translational Psychiatry · 2022-02-22A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.Frontiers in Psychiatry · 2021-12-06Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity.Translational Psychiatry · 2021-10-016.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDERJournal of the American Academy of Child & Adolescent Psychiatry · 2021-09-30Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.Frontiers in Psychiatry · 2021-09-05Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in Psychiatry · 2021-08-05Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.Frontiers in Psychiatry · 2021-06-28Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.Frontiers in Psychiatry · 2021-06-15The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.Pharmacopsychiatry · 2021-05-11Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-ProcessingBiological Psychiatry · 2021-04-26Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening CancerBiological Psychiatry · 2021-04-26Psilocybin: From Serendipity to Credibility?Frontiers in Psychiatry · 2021-04-20Spontaneous and deliberate creative cognition during and after psilocybin exposure.Translational Psychiatry · 2021-04-07Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?European Psychiatry · 2021-03-31Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean Psychiatry · 2021-03-31Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2020-12-31A "Trip" to the Intensive Care Unit: An Intravenous Injection of Psilocybin.Journal of the Academy of Consultation-Liaison Psychiatry · 2020-12-31Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry · 2020-11-03Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12Psilocybin-assisted therapy for depression: How do we advance the field?Australian & New Zealand Journal of Psychiatry · 2019-11-21T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30Psychedelics as anti-inflammatory agents.International Review of Psychiatry · 2018-08-12Psilocybin and Mental Health-Don't Lose Control.Frontiers in Psychiatry · 2018-07-02T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking SmokersBiological Psychiatry · 2018-04-08LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.Nordic Journal of Psychiatry · 2017-07-04Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The Lancet Psychiatry · 2016-05-16Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British Journal of Psychiatry · 2012-01-25The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.Biological Psychiatry · 2010-12-02Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.Archives of General Psychiatry · 2010-09-05Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive DisorderYearbook of Psychiatry and Applied Mental Health · 2007-12-31Psilocybin Results Inspire ResearchersClinical Psychiatry News · 2007-06-30Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of Clinical Psychiatry · 2006-10-31Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.Pharmacopsychiatry · 2005-10-31Hallucinogen persisting perception disorder after psilocybin consumption: a case study.European Psychiatry · 2005-07-31Psilocybin-Induced Transformations of Visual SpacePharmacopsychiatry · 1970-06-30Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial DistortionPharmacopsychiatry · 1969-10-31Psilocybin-induced Autonomic, Perceptual, and Behavioral ChangePharmacopsychiatry · 1968-10-31Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteersComprehensive Psychiatry · 1960-11-30